
BostonGene
Developer of a biomedical software designed for advanced patient analysis and personalized therapy. The company's software offers an artificial intelligence-powered molecular genetic and immune profil...
Valuation
$1.5B
Latest known
Share Price
N/A
Total Raised
$320M
Last Round
N/A